Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
When diabetes isnt the main problem, how do you keep glucose control on track without compromising treatment for Read More CGM in Primary Care: Bridging the Endocrinology Gap Dec 4, 2025 Articles, Blood Glucose Control, Devices, Diabetes, Physician oriented, Type 2 Diabetes 1,181 views Could continuous glucose monitoring (CGM) soon become the norm in primary care
[31] A large study found that GLP-1 RA use was associated with lower risk of developing immune-mediated inflammatory diseases in patients with type 2 diabetes or obesity, suggesting a potential protective effect in some cohorts.[42] What the science is showing is potential for improvements: GLP-1RAs reduce blunt activation in fibroblast-like synoviocytes and improve joint inflammation and metabolic parameters in rheumatoid arthritis models and small human cohorts.[26][29][25] [31] Early clinical studies and case series in RA patients (especially those with coexisting type 2 diabetes or obesity) reported reduced disease activity scores (DAS28), lower C-reactive protein and erythrocyte sedimentation rate levels, fewer swollen joints, and diminished morning stiffness during GLP-1RA treatment, along with the expected weight reduction and improved insulin sensitivity.[31] Psoriasis showed improved PASI scores and quality-of-life metrics in patients with T2DM and psoriasis, alongside reductions in lesional skin and peripheral TNF-producing monocytes.[26] Case series show meaningful skin improvement.[26] In psoriasis and psoriatic arthritis , GLP-1RA therapy has been associated with improvements in inflammatory markers and disease severity indices
He is also senior group leader at the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
How GLP-1 Functions in the Body The gut produces a hormone called GLP-1, or glucagon-like peptide-1
Higher risks may occur when patients: self-dose without supervision buy peptides from unregulated websites use incorrect dosing combine multiple peptides improperly skip follow-up monitoring ignore nutrition and hydration Patients sometimes assume peptide therapy is natural and therefore completely risk-free
Any form of misbranding, misuse, or mislabeling is strictly prohibited
